Adicet Bio, Inc. Common Stock (ACET) Stock Price

ACETStock

$9.00−23.47%52W

Market Cap$84.25M

P/E—

PEG Ratio—

Div yield—

Beta1.63

ACET Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)14.82%

Price vs S&P 500 (4W)5.48%

VGM Score67.29

Book Value / Share (Quarterly)$12.83

P/TBV (Annual)2.20x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-9.08

Price vs S&P 500 (YTD)-6.26%

Net Profit Margin (TTM)-93.15%

EPS (TTM)$-13.02

10-Day Avg Trading Volume0.07M

EPS Excl Extra (TTM)$-13.02

EPS (Annual)$-1.33

ROI (Annual)-62.70%

Net Profit Margin (5Y Avg)-548.85%

Cash / Share (Quarterly)$12.63

ROA (Last FY)-53.13%

EBITD / Share (TTM)$-11.52

ROE (5Y Avg)-44.86%

Operating Margin (TTM)-91.40%

Cash Flow / Share (Annual)$-10.12

P/B Ratio0.65x

P/B Ratio (Quarterly)0.67x

Net Income / Employee (Annual)$-1,147,100

EV / Revenue (TTM)1.18x

Net Interest Coverage (TTM)-689.22x

ROA (TTM)-60.87%

EPS Incl Extra (Annual)$-1.33

Current Ratio (Annual)7.47x

Quick Ratio (Quarterly)6.59x

3-Month Avg Trading Volume0.09M

52-Week Price Return-23.47%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$7.63

P/S Ratio (Annual)3.12x

Asset Turnover (Annual)0.08x

52-Week High$17.44

Operating Margin (5Y Avg)-566.93%

EPS Excl Extra (Annual)$-1.33

CapEx CAGR (5Y)11.91%

Tangible BV CAGR (5Y)40.58%

26-Week Price Return26.06%

Quick Ratio (Annual)7.38x

13-Week Price Return12.80%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)6.71x

Enterprise Value$45.55M

Asset Turnover (TTM)0.13x

Book Value / Share Growth (5Y)24.40%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-279.27%

Cash / Share (Annual)$16.54

3-Month Return Std Dev66.57%

Net Income / Employee (TTM)$-970,300

ROE (Last FY)-62.70%

EPS Basic Excl Extra (Annual)$-1.33

Receivables Turnover (TTM)249.90x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-13.02

Receivables Turnover (Annual)270.16x

ROI (TTM)-74.37%

P/S Ratio (TTM)2.01x

Pretax Margin (5Y Avg)-554.32%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$7.63

Price vs S&P 500 (52W)-41.78%

Year-to-Date Return5.70%

5-Day Price Return-2.31%

EPS Normalized (Annual)$-1.33

ROA (5Y Avg)-37.04%

Net Profit Margin (Annual)-279.27%

Month-to-Date Return-2.31%

Cash Flow / Share (TTM)$-3.21

EBITD / Share (Annual)$-1.38

Operating Margin (Annual)-290.32%

ROI (5Y Avg)-44.86%

EPS Basic Excl Extra (TTM)$-13.02

P/TBV (Quarterly)2.20x

P/B Ratio (Annual)0.51x

Pretax Margin (TTM)-93.36%

Book Value / Share (Annual)$16.61

Price vs S&P 500 (13W)10.01%

Beta1.63x

Revenue / Share (TTM)$0.00

ROE (TTM)-74.90%

52-Week Low$6.01

vGradeA

mGradeC

vgmGradeB

ACET Earnings Surprise History

Q2 25-5.44est. -4.75

Q3 25-4.64est. -5.07

Q4 25-2.94est. -2.99

Q1 26-1.88est. -3.08

Q2 26-1.99est. -1.64

ACET Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.31

4.33

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
ACETAdicet Bio, Inc. Common Stock	A	—	C	$9.00
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Adicet Bio, Inc. Common Stock

Adicet Bio is a clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases. ADI-001, its lead candidate, is a CD20-targeting CAR T cell therapy in development for relapsed or refractory B cell lymphomas and autoimmune indications. The company's pipeline also includes ADI-270, a preclinical CAR T program targeting CD70 for renal cell carcinoma and other solid tumors.